Skip to content
Search

Latest Stories

As surveys to review PSNC, LPC support for contractors are set to go live, Hemant Patel launches attack on PSNC

An independent review to examine the roles and structures underpinning PSNC and the local pharmaceutical committees (LPCs) has moved into its second phase.

It's chair, Professor David Wright, has asked all contractors and LPCs to express their views via two surveys which are being launched tomorrow.


The review team led by Professor Wright is seeking views on LPC and PSNC structures, support, representation, communication and governance.

The purpose of the review is to enable the infrastructure to capitalise on the changing nature of healthcare within England on behalf of pharmacy contractors, who can access the survey via this link which closes on February 29.

PATEL LAUNCHES ATTACK ON PSCN

As the review team now focusses on listening to PSNC committee members and employees to obtain their perspective on the current system and how it can provide further value to contractors, the Secretary of the North East London LPC, Hemant Patel has accused PSNC of operating in a “secretive and undemocratic manner” in the way in which it agreed the new Community Pharmacy Contractual Framework (CPCF).

 

In a hard-hitting letter to Professor David Wright sent earlier this month, Patel wrote: “The secrecy with which PSNC agreed the last CPCF is only matched by [the] Kremlin.”

He said without holding any consultations with the LPCs, the pharmacy contract negotiator (PSNC) would “change their constitution and regional boundaries.”

THE BMA EXAMPLE

“Very different to the how BMA makes decisions,” he wrote. The British Medical Association (BMA), which represents the general practitioners in their contract negotiations with the government, recently voted to hold a special conference after its GP committee formally rejected the contract package and draft service specifications and called for a special conference of local medical committees.

Patel also asked Professor Wright to ensure that the review he is currently undertaking “must compare and contrast how the two professions’ negotiators treat the levy paying contractors” they represent.

The letter continued: “There is no presentation of the annual report and accounts to the LPCs. Again, this is very odd.

“LPCs are required to present annual accounts and report to the levy paying contractors. Some LPCs do not present their accounts to their levy paying contractors. This again should be unacceptable and change.”

He concluded by asking Prof Wright to take “democratic principles” into consideration by paying equal attention to both the “representative government (PSNC and LPCs) and the consent of the governed (pharmacy contractors).”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less